ARA 290  10mg
Longevity & Neuro Research
Research Use Only — Not for Human or Veterinarian Administration

ARA 290 10mg

ARA-290 (Cibinetide) is an 11-amino-acid peptide derived from the helix-B domain of erythropoietin, studied for tissue protection and neuropathic pain in research models without erythropoietic activity.

ARA 290 10mg$58.00
View only
View Certificate of AnalysisThird-party HPLC lab report · opens PDF

Mechanism of Action

Activates the innate repair receptor (IRR), a heteromer of EPO receptor and CD131, triggering anti-inflammatory and tissue-protective pathways without stimulating red blood cell production.

Research Applications

  • Innate repair receptor (IRR) activation assays
  • Neuropathic pain model research
  • Ischemia-reperfusion injury studies

Specifications

sequence11-aa EPO-derived peptide (Cibinetide)
molecular Weight~1250 Da
appearanceWhite lyophilized powder

Reconstitution (Laboratory)

Reconstitute with bacteriostatic water under sterile conditions.

Storage & Handling

Lyophilized: 2–8 °C. Reconstituted: refrigerate.

Quality Assurance

Every lot undergoes independent third-party HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin testing (<0.5 EU/mg). Certificate of Analysis (COA) is stored against the SKU lot number and available through your research account portal.

Sources & References

  1. 1.Brines M, et al. Erythropoietin mediates tissue protection through an innate repair receptor. Proc Natl Acad Sci. 2004. · PubMed →
  2. 2.Dahan A, et al. ARA 290 improves symptoms in patients with sarcoidosis. Mol Med. 2013. · PubMed →